IL-10 suppresses experimental autoimmune neuritis and down-regulates T(H)1-type immune responses

Clinical Immunology and Immunopathology

Volumn 83, Issue 2, 1997, Pages 117-126

  Bai, Xue Feng ^a   Zhu, Jie ^a   Zhang, Guang Xian ^a   Kaponides, Georgios ^a   Höjeberg, Bo ^a   Van Der Meide, Peter H ^b   Link, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ETIOLOGY; MALE; NEURITIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0030907687     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4331     Document Type: Article

References (40)

1. Waksman B. H., Adams R. D. Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvant. J. Exp. Med. 102:1955;213-225.
2. Kadlubowski M., Hughes R. A. C. Identification of the neuritogen for experimental allergic neuritis. Nature. 277:1979;140-141.
3. Suzuki M., Kitamura K., Uyemura K., Ogawa Y., Ishihara Y., Matsuyama H. Neuritogenic activity of peripheral nerve myelin proteins in Lewis rats. Neurosci. Lett. 19:1980;353-358.
4. Milner P., Lovelidge C. A., Taylor W. A., Hughes R. A. C. P0 myelin protein produces experimental experimental allergic neuritis in Lewis rats. J. Neurol. Sci. 79:1987;275-285.
5. Adelmann M., Linington C. Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein. Neurochem. Res. 17:1992;887-891.
6. Shin H. C., McFarlane E. F., Pollard J. D., Watson E. G. Induction of experimental allergic neuritis with synthetic peptides from myelin P2 protein. Neurosci. Lett. 102:1989;309-312.
7. Olee T., Powell H. C., Brostoff S. W. New minimum length requirement for a T cell epitope for experimental allergic neuritis. J. Neuroimmunol. 27:1990;187-190.
8. Kiefer R., Gold R., Gehrmann J., Lindholm D., Wekerle H., Kreutzberg G. W. Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis. J. Neurosci. Res. 36:1993;391-398.
9. Linington C., Izumo S., Suzuki M., Uyemura K., Meyermann R., Wekerle H. A permanent rat cell line that mediates experimental allergic neuritis in the Lewis rats in vivo. J. Immunol. 133:1984;1946-1950.
10. Linington C., Lassmann H., Ozawa K., Kosin S., Mongan L. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: Induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur. J. Immunol. 22:1992;1813-1817.
11. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:1995;246-268.
12. Schmidt B., Stoll G., van der Meide P., Jung S., Hartung H. P. Transient cellular expression of γ-interferon in myelin-induced and T cell line-mediated experimental autoimmune neuritis. Brain. 115:1992;1633-1646.
13. Zhu J., Link H., Mix E., Olsson T., Huang W. X. Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats. Acta Neurol. Scand. 90:1994;19-25.
14. Zhu J., Mix E., Olsson T., Link H., Cellular mRNA expression of interferon-gamma IL-. 4 and transforming growth factor-beta (TGF-β) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis. Clin. Exp. Immunol. 98:1994;306-312.
15. Zhu J., Mix E., Issazadeh S., Link H. Dynamics of mRNA expression of interferon-γ, interleukin 4 and transforming growth factor β1 in sciatic nerves and lymphoid organs in experimental allergic neuritis. Eur. J. Neurol. 3:1996;1-9.
16. Hartung H. P., Pollard J. D., Harvey G. K., Toyka K. V. Immunopathogenesis and treatment of the Guillain-Barré syndrome part I. Muscle Nerve. 18:1995;137-153.
17. Howard M., O'Garra A. Biological properties of interleukin-10. Immunol. Today. 13:1992;198-200.
18. Macatonia S. E., Doherty T. M., Knight S. C., O'Garra A. Differential effect of interleukin 10 on dendritic cell-induced T-cell proliferation and interferon production. J. Immunol. 150:1993;3755-3765.
19. Fernandez-Botran R., Sanders V. M., Mosmann T. R., Vitetta E. S. Lymphokine mediated regulation of the proliferative responses of clones of T helper 1 and T helper 2 cells. J. Exp. Med. 168:1988;543-558.
20. Kadlubowski M., Hughes R. A. C., Gregson N. A. Experimental allergic neuritis in the Lewis rat: Characterization of the activity of peripheral myelin and its major basic protein P2. Brain Res. 184:1980;439-454.
21. Lindström J., Einarson B., Tzartos S. Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 74:1981;432-460.
22. van der Meide P. H., Dubbeld M., Vijverberg K., Kos T., Schellekens H. The purification of gamma interferon by use of two monoclonal antibodies. J. Gen. Virol. 67:1986;1059-1071.
23. Hofman F. M., Yanagihara E. Y., Byrne B., Billing R., Baird S., Frisman D., Taylor C. R. Analysis of B cell antigens in normal reactive lymphoid tissue using four B cell monoclonal antibodies. Blood. 62:1983;775-783.
24. Olsson T., Bakhiet M., Höjeberg B., Ljungdahl Å., Edlund C., Andersson G., Ekre H.-P., Fung Leung W.-P., Mark T., Wigzell H., Fiszer U., Kristensson K. CD8 is critically involved in lymphocyte activation by a Trypanosoma brucei brucei released molecule. Cell. 72:1993;715-727.
25. Olsson T., Wang W.-Z., Höjeberg B., Kostulas V., Jiang Y.-P., Andersson G., Ekre H.-P., Link H. Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of interferon-gamma. J. Clin. Invest. 86:1990;981-985.
26. Mix E., Olsson T., Solders G., Link H. Effect of ion channel blockers on immune response and course of experimental allergic neuritis. Brain. 112:1989;1405-1418.
27. Pennline K. J., Roque-Gaffney E., Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71:1994;169-175.
28. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1994;1434-1440.
29. Hartung H. P., Schäfer B., van der Meide P. H., Fierz W., Heininger K., Toyka K. V. The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann. Neurol. 27:1990;247-257.
30. Strigård K., Holmdahl R., van der Meide P. H., Klareskog L., Olsson T. In vivo treatment of rats with monoclonal antibodies against gamma interferon: Effects on experimental allergic neuritis. Acta Neurol. Scand. 80:1989;201-207.
31. Stoll G., Jung S., Jander S., van der meide P., Hartung H. P. Tumor necrosis factor-α in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J. Neuroimmunol. 45:1993;175-182.
32. Said G., Hontebeyrie-Joskowicz M. Nerve lesions induced by macrophage activation. Res. Immunol. 143:1992;589-599.
33. Jung S., Huitinga I., Schmidt B., Zielasek J., Dijkstra C. D., Toyka K. V., Hartung H. P. Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis. J. Neurol. Sci. 119:1993;195-202.
34. Zettl U. K., Gold R., Hartung H. P., Toyka K. V. Apoptotic cell death of T-lymphocytes in experimental autoimmune neuritis of the Lewis rat. Neurosci. Lett. 176:1994;75-79.
35. Kiefer R., Funa K., Schweitzer T., Jung S., Bourde O., Toyka K. V., Hartung H. P. Transforming growth factor-β1 in experimental autoimmune neuritis: Cellular localization and time course. Am. J. Pathol. 148:1996;211-223.
36. Powrie F., Menon S., Coffman R. L. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Res. Immunol. 23:1993;2223-2229.
37. Mosmann T. R., Coffman R. L. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
38. Mosmann T. R., Moore K. W. The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunol. Today. 12:1991;A49-A53.
39. Wogensen L., Lee M. S., Sarvetnick N. Production of interleukin-10 by islet cells accelerates immune-mediated destruction of cells in nonobese diabetic mice. J. Exp. Med. 179:1994;1379-1384.
40. Wogensen L., Huang X., Sarvetnick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin-10 in the islets of Langerhans. J. Exp. Med. 178:1993;175-185.